EGFR and lung adenocarcinoma: By matching cell line sensitivity to BIM and mTOR expression, we observed that inhibition concentration of 50% cell viability (IC50) induced by gefitinib was increased as mTOR expression increased, in the three sensitive and high BIM expressing EGFR-mutant lung adenocarcinoma cell lines, H3255, PC-9 and 11–18.